Mild Pulmonary Venous Congestion and Bibasilar Atelectasis
Mild pulmonary venous congestion is managed with decongestion therapy using diuretics to relieve congestion and improve symptoms. [1] Bibasilar atelectasis is managed by treating the underlying cause and promoting lung re-expansion with lung expansion measures. [2][3]
Congestion Treatment Strategy
Loop diuretics are recommended for patients with heart failure who have fluid retention to relieve congestion and improve symptoms. [1] In patients admitted with evidence of significant fluid overload, intravenous loop diuretics should be used promptly to improve symptoms and reduce morbidity. [1] In hospitalized patients, diuretic therapy should be titrated with a goal to resolve clinical evidence of congestion to reduce rehospitalizations. [1] For patients with inadequate diuresis despite initial therapy, diuretic intensification is reasonable using either higher-dose intravenous loop diuretics or addition of a second diuretic. [1]
Atelectasis Treatment Strategy
Atelectasis management should focus on treating the underlying cause and re-expanding collapsed lung tissue. [2][3] Lung expansion maneuvers used in practice include deep-breathing exercises, coughing, and incentive spirometry. [4] Early mobilization is recommended to support lung expansion and secretion clearance. [3]
Supportive Respiratory Care
Supplemental oxygen is used to treat hypoxemia due to atelectasis or coexisting pulmonary processes. [2] Noninvasive respiratory support is used when respiratory failure is present or developing. [5]
Medication and Diagnostic Nuances
Congestion management should include assessment for precipitating contributors and comorbid triggers of decompensation since the pulmonary congestion finding reflects elevated cardiac filling pressures. [1] If atelectasis persists, worsens, or is associated with fever, pleuritic pain, or leukocytosis, alternative or superimposed diagnoses (including pneumonia or aspiration) should be evaluated because atelectasis can rapidly transition into infectious complications. [2]
Monitoring and Reassessment
Congestion-directed therapy should be reassessed using clinical evidence of congestion resolution during hospitalization. [1] Atelectasis-directed therapy should be reassessed based on symptom response and radiographic trajectory after implementing lung expansion and mobilization measures. [2][3]
Common Pitfalls to Avoid
Routine prophylactic incentive spirometry after surgery is not recommended based on guideline evidence. [6] Atelectasis management should not ignore the underlying cause since ongoing atelectasis risk persists without lung re-expansion and treatment of contributors. [2][3]
Targets of Therapy
The clinical target for congestion management is resolution of clinical evidence of congestion to reduce symptoms and rehospitalizations. [1] The clinical target for atelectasis management is re-expansion of collapsed lung tissue with resolution of impaired ventilation. [2][3]